Clinical Trials at Memorial Sloan Kettering Bergen (Limited Protocol Activities)
As of August 2026, 109 paid clinical trials are recruiting at Memorial Sloan Kettering Bergen (Limited Protocol Activities), located at 225 SUMMIT AVE, MONTVALE, NJ 07645-1523, phone (212) 639-2000 in Montvale, New Jersey. Active studies at this site cover conditions such as Breast Cancer, Multiple Myeloma and Acute Myeloid Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Montvale
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Luspatercept in People With Anemia
111 clinical trials at Memorial Sloan Kettering Bergen (Limited Protocol Activities)
·Clear filters·A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
A Study of Ivonescimab in People With Leiomyosarcoma
A Study of Mirdametinib in People With Central Nervous System Tumors
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Factors Associated With Breast Cancer Risks and Outcomes
A Registry for People With Lung Cancer
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
A Study of 177Lu-PSMA-617 in People With Gliomas
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Study of Aerobic Training for People Receiving Treatment for Breast Cancer
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
A Dietary Study for People With Multiple Myeloma
A Study of Tarlatamab for People With Prostate Cancer
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
A Study of CRD3874-SI in People With Solid Tumors
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
Common conditions studied in Montvale
- Breast Cancer (29 active studies)
- Multiple Myeloma (13 active studies)
- Acute Myeloid Leukemia (11 active studies)
- Prostate Cancer (11 active studies)
- Metastatic Breast Cancer (9 active studies)
- Non-Small Cell Lung Cancer (9 active studies)
Leading research sponsors in Montvale
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Pfizer
Frequently asked questions
How many paid clinical trials are currently recruiting in Montvale?
There are approximately 304 recruiting clinical trials in Montvale, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Montvale pay participants?
Most recruiting trials in Montvale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Montvale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Montvale?
The most common conditions under active study in Montvale include Breast Cancer (29), Multiple Myeloma (13), Acute Myeloid Leukemia (11), Prostate Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Montvale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Montvale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Montvale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Montvale?
Recruiting research sites in Montvale include Memorial Sloan Kettering Bergen (Limited Protocol Activities), Memorial Sloan Kettering Bergen, Memorial Sloan Kettering Bergen (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Montvale right now?
The largest active categories in Montvale are Cancer & tumors (248), Neurology & pain (2), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Memorial Sloan Kettering Bergen (Limited Protocol Activities)?
Memorial Sloan Kettering Bergen (Limited Protocol Activities) is located at 225 SUMMIT AVE, MONTVALE, NJ 07645-1523. Use the Google Maps link in the intro above to get directions.
How do I contact Memorial Sloan Kettering Bergen (Limited Protocol Activities)?
You can reach Memorial Sloan Kettering Bergen (Limited Protocol Activities) by phone at (212) 639-2000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.